auwkeurigheid van partiele borstbestraling met het Cyberknife
Not yet recruiting
- Conditions
- Breast cancerBorstkankerMamma carcinoom
- Registration Number
- NL-OMON25451
- Lead Sponsor
- Erasmus MC, Rotterdam, The Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 52
Inclusion Criteria
Female
-Age > or = 50 years
Exclusion Criteria
-Lympho-vascular infiltration
-Extensive intraductal component
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method geometric uncertainty of Cyberknife APBI and required PTV margin
- Secondary Outcome Measures
Name Time Method - Proportion of patients where the surgical clips and superficial gold markers can successfully be used as fiducials<br /><br>- Dosimetric gain of PTV margin reduction<br /><br>- Acute toxicity
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does Cyberknife's geometric accuracy in partial breast irradiation compare to standard surgical clips as fiducial markers?
What are the long-term outcomes of accelerated partial breast irradiation using Cyberknife in early-stage breast cancer patients?
Do tumor size or breast density affect Cyberknife's targeting precision in partial breast irradiation with surgical clips?
What adverse events are associated with Cyberknife-based partial breast irradiation versus conventional external beam therapy?
How do surgical clip placement techniques influence Cyberknife's geometric accuracy in breast cancer radiation trials?